Healthlynked Corp (HLYK) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Healthlynked Corp (HLYK) stock forecast summary
Our AI ranks Healthlynked Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Healthlynked Corp is a small-cap company with a market capitalization of $6M. It ranks number 7 by market capitalization among the 8 Services-Offices & Clinics of Doctors of Medicine issuers in our coverage with a current forecast. Its Current Ratio of 0.17x is the lowest of the 8 peers that report one.
For HLYK, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 24.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 11.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.7%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, HLYK included.
Follow HLYK freeHLYK price chart and AI forecast
How HLYK ranks among 5171 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Healthlynked Corp (HLYK) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Offices & Clinics of Doctors of Medicine peers listed below that report each metric.
Valuation & Market
| Metric | HLYK | Rank |
|---|---|---|
| Market Cap | $6M | 7/8 |
| EPS | $-2.00 | – |
| Revenue/Share | $0.46 | – |
Profitability & Margins
| Metric | HLYK | Rank |
|---|---|---|
| ROA | -238.2% | 6/6 |
| ROIC | 31.5% | 1/8 |
| Operating Margin | -177.8% | 8/8 |
| Net Margin | -293.3% | 6/6 |
| EBT Margin | -199.6% | 8/8 |
Financial Health
| Metric | HLYK | Rank |
|---|---|---|
| Current Ratio | 0.17x | 8/8 |
| Quick Ratio | 0.17x | 6/6 |
| Interest Coverage | -52.7x | 6/8 |
| Working Capital | -$7M | 5/8 |
Cash Flow
| Metric | HLYK | Rank |
|---|---|---|
| Operating Cash Flow | -$2M | 6/8 |
Operational Efficiency
| Metric | HLYK | Rank |
|---|---|---|
| Asset Turnover | 0.86x | 4/7 |
| Fixed Assets Turnover | 35.7x | 4/6 |
Income Statement
| Metric | HLYK | Rank |
|---|---|---|
| Total Revenue | $1M | 7/7 |
| Operating Income | -$2M | 3/8 |
| Net Income | -$4M | 4/6 |
| SG&A Expense | $2M | 7/7 |
Dividend & Shareholder Information
| Metric | HLYK | Rank |
|---|---|---|
| Shares Outstanding | 3M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $2M | 96.9% of assets |
| Cash & Short-term Investments | $10K | 0.6% of assets |
| Inventory | $20K | 1.3% of assets |
| Total Liabilities | $9M | |
| Short-term Debt | $8M |
HLYK quarterly financials and insider trading
Healthlynked Corp (HLYK) industry peers
Companies classified under the same SEC industry code as Healthlynked Corp (Services-Offices & Clinics of Doctors of Medicine): 8 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| HLYK Healthlynked Corp | ▲ | $6M |
| HIMS Hims & Hers Health, Inc. | ▲ | $6.39B |
| TDOC Teladoc Health, Inc. | ▲ | $1.08B |
| STLN Starling Oncology, Inc. | ▲ | $680M |
| SBC Sbc Medical Group Holdings Inc | ▶ | $545M |
| LFMD Lifemd, Inc. | ▶ | $119M |
| AIRS Airsculpt Technologies, Inc. | ▲ | $92M |
| CDIX Cardiff Lexington Corp | ▼ | $1M |
Where HLYK sits on the market map
Healthlynked Corp (HLYK) stock news
Loading...
Healthlynked Corp (HLYK) stock forecast FAQ
What is the Healthlynked Corp (HLYK) stock forecast?
Our AI ranks Healthlynked Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Healthlynked Corp stock predictions?
For HLYK, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 24.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 11.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Healthlynked Corp forecasts updated?
Healthlynked Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Healthlynked Corp's industry peers?
8 issuers in our coverage, HLYK included, share the SEC industry code Services-Offices & Clinics of Doctors of Medicine. The largest are: Hims & Hers Health, Inc. (HIMS), Teladoc Health, Inc. (TDOC), Starling Oncology, Inc. (STLN), Sbc Medical Group Holdings Inc (SBC), Lifemd, Inc. (LFMD), Airsculpt Technologies, Inc. (AIRS).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.